Recall events
/
Event 86579
Event summary
Timeline bucket October 09, 2020
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Milbar Laboratories, Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
14 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 14
DCL Active Mattifying Cleanser (Salicylic Acid 2%), 125mL/4.2 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486509627
D-0083-2021
Recall number D-0083-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 4,878 tubes
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot # FW937, Exp. Date Jun-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12351]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 14
DCL B Prox10 Anti-Blemish Wash (Benzoyl Peroxide 10%), 200 ml/6.7 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 0357486500853
D-0084-2021
Recall number D-0084-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 7,591 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot # MV098-4, Exp. Date Dec-21 Lot #: JW995, Exp. Date Sep-22 Lot #: Fx381, Exp. Date Jun-23
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12279]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 14
DCL AHA Lightening Gel (hydroquinone 2%), 30 ml/1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486500471
D-0085-2021
Recall number D-0085-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 1,608 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: LW110-3, Exp. Date Nov-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12187]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 14
DCL SA Scalp Therapy Shampoo (Salicylic Acid 3%) 300 ml/10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486503120
D-0086-2021
Recall number D-0086-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 1,815 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: KV092-3, Exp. Date Nov-21 Lot #: FX456-7, Exp. Date Jun-23
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12147]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 14
DCL T Shampoo for Hair and Body ( Solution Coal Tar U.S.P. 3% and 0.6% Coal Tar), 300 ml/ 10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 3574865069947
D-0087-2021
Recall number D-0087-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 1,225 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: DW913-9, Exp. Date Apr-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12281]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 14
(Malin + Goetz) dandruff Shampoo Psoriasis and Sebborrheic Dermatitis (1.9% Pyrithione Zinc) 8 fl.oz bottle, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
D-0088-2021
Recall number D-0088-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 5,312 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: GW905-5, Exp. Date Jul-22 Lot #: KV428-3, Exp. Date Oct-21
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12391]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 14
(Malin + Goetz) Salicylic Gel (2% Salicylic Acid) 0.5 fl.oz. 15 mL tube, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
D-0089-2021
Recall number D-0089-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 2,664 tubes
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: MV678, Exp. Date Dec-21
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12320]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 14
(Malin+Goetz) spf 30 face moisturizer (Avobenzone 3%, Homosalate 10 %, Octinoxate 7.5%, Octisalate 2.75%, Oxybenzone 5%) 1.7 fl. oz. 50 ml tubes, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
D-0090-2021
Recall number D-0090-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 3,692 tubes
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: AW761-9, Exp. Date Jan-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12152]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 14
MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN
D-0091-2021
Recall number D-0091-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 2,655 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: DX278, Exp. Date Apr-23
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12146]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 14
Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist. Chandler, AZ 85226
D-0092-2021
Recall number D-0092-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 4,855 tubes
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: DW827-4, Exp. Date Mar-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12287]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 14
Willa Pore Perfector (Salicylic Acid 2%) pads, 30 pads
D-0093-2021
Recall number D-0093-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 2,638 plastic jars
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: CW828-0, Exp. Date Mar-22
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12285]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 14
DCL Alpha Beta Gel Toner (1.95% Salicylic Acid) 200 mL/6.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
D-0094-2021
Recall number D-0094-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 2,335 bottles
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot # HV093-6, exp. date Aug-21
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12150]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 14
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
D-0095-2021
Recall number D-0095-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 927 tubes
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: FX432-5, Exp. Date June-21
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12395]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 14
Salicylic Acid Shampoo 3%, Bulk Product, 360 Therapeutics
D-0096-2021
Recall number D-0096-2021
Initiated October 09, 2020
Classification Class II
Status Terminated
Quantity 198.8 kg
App-derived interpretation
Manufacturing or process control
reason.manufacturing_process_control · v1.0.0
GMP Deviations
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall GMP Deviations
Code information Lot #: HV349
Distribution pattern Product was distributed throughout the United States, including Puerto Rico and internationally.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12144]
FDA event record
· Exact recall-number query on openFDA